Drug Type mRNA |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Elixirgen Therapeutics, Inc.Startup |
Active Organization- |
Inactive Organization Elixirgen Therapeutics, Inc.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Down Syndrome | Discovery | US | Elixirgen Therapeutics, Inc.Startup | 23 Mar 2022 |